Get started
Author

Per Grimfjärd

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
2017 · David Erlinge, Elmir Omerovic, et al. · New England Journal of Medicine · 310
PDF
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
2022 · Sunil V. Rao, Bodo Kirsch, et al. · Circulation · 182
PDF
Experience in treatment of metastatic pulmonary carcinoid tumors
2001 · D. Granberg, B. Eriksson, et al. · Annals of Oncology · 147
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
2020 · Moman A Mohammad, Sasha Koul, et al. · Heart · 59
PDF
Transfection of the Multiple Endocrine Neoplasia Type 1 Gene to a Human Endocrine Pancreatic Tumor Cell Line Inhibits Cell Growth and Affects Expression of JunD, δ-Like Protein 1/Preadipocyte Factor-1, Proliferating Cell Nuclear Antigen, and QM/Jif-1
2004 · Peter Stålberg, Per Grimfjärd, et al. · The Journal of Clinical Endocrinology & Metabolism · 59
Co‐expression of ghrelin and its receptor in pancreatic endocrine tumours
2006 · Sara Ekeblad, Margareta Halin Lejonklou, et al. · Clinical Endocrinology · 54
Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
2019 · Per Grimfjärd, Bo Lagerqvist, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 45
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial
2024 · David Erlinge, Jonas Andersson, et al. · The Lancet · 37
Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
2024 · Sacharias von Koch, Mikael Zhou, et al. · Journal of the American Heart Association · 28
PDF
Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction
2021 · Stefan James, Sasha Koul, et al. · Circulation Cardiovascular Interventions · 21
PDF
Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
2021 · Sergio Buccheri, Giovanna Sarno, et al. · EuroIntervention · 17
Annual report SWEDEHEART 2012
2014 · Anna-Maria Wahlberg, Magdalena Alenström, et al. · Scandinavian Cardiovascular Journal · 17
Cangrelor During Percutaneous Coronary Intervention in Patients With Cardiogenic Shock or Cardiac Arrest
2025 · Oskar Love Emilsson, Moman A. Mohammad, et al. · JACC: Cardiovascular Interventions · 14
Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction
2018 · David Erlinge, Sasha Koul, et al. · European Heart Journal Acute Cardiovascular Care · 13
Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR Report
2024 · Saman Saidi-Seresht, Stefan James, et al. · Journal of the Society for Cardiovascular Angiography & Interventions · 10
PDF
Prognostic value of early sustained ventricular arrhythmias in ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: A substudy of VALIDATE-SWEDEHEART trial
2022 · Marina M. Demidova, Rebecca Rylance, et al. · Heart Rhythm O2 · 10
PDF
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment: A nationwide Swedish registry report
2016 · Per Grimfjärd, David Erlinge, et al. · American Heart Journal · 9
Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold: data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
2017 · Per Grimfjärd, Stefan James, et al. · EuroIntervention · 8
PDF
Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report
2021 · Per Grimfjärd, Elin Bergman, et al. · Catheterization and Cardiovascular Interventions · 7
PDF
Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry
2024 · Sacharias von Koch, Sasha Koul, et al. · Heart · 6
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study
2017 · Per Grimfjärd, David Erlinge, et al. · EuroIntervention · 6
Long-Term Outcome of Percutaneous Coronary Intervention Using Absorb Bioresorbable Scaffold: A SCAAR Study
2025 · Saman Saidi-Seresht, Sacharias von Koch, et al. · Journal of the Society for Cardiovascular Angiography & Interventions · 4
PDF
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with drug coated balloons in acute coronary syndromes: insights from the SWEDEHEART registry
2026 · Anton Håkansson, Sacharias von Koch, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2
Percutaneous coronary intervention of in-stent restenosis: A three-arm analysis from SWEDEHEART
2024 · S Von Koch, M Zhou, et al. · European Heart Journal · 2
Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays.
2009 · Juan R Lopez-Egido, Yi Wang, et al. · PubMed · 2
Works count: 32
Citation count: 1,070
H-index: 13
I10-index: 16
Year
Topic
Type